Transaction · 0000905148-26-004080

Schorno Dean L

Schorno Dean L, EVP, CFO, reported a transaction classified as exercise at RIGEL PHARMACEUTICALS INC involving 694.000000 shares for an estimated $0.00. Reported holdings after the transaction were 12824.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MEVP, CFO
RIGLRIGEL PHARMACEUTICALS INC
Trade date
Sep 02, 2026
Filing date
Sep 03, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded694$0.00 per share
Holdings after12.8kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

RIGL price since this filing

Daily closing prices, with the filing date and available return windows
RIGL · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -18.9%1w ago +0.0%1d ago +0.0%
Returns since7d +2.5%30d +2.2%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0000905148-26-004080
Employee Stock Option (right to buy)
Transaction date
Sep 02, 2026
Filed Sep 03, 2026, 11:02 PM · 1d delay
Shares
694 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
12,824 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 1

    Filing reported within two business days of the transaction.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP & Chief Financial Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes 500 shares acquired under the Issuer's stock purchase plan.

  2. F2

    These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.

  3. F3

    The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 23, 2024, subject to the Reporting Person's continuous service to the I…

  4. F4

    The shares of common stock subject to the option vest monthly over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Iss…

  5. F5

    The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2022, subject to the Reporting Person's continuous service to the I…

  6. F6

    The shares of common stock subject to the option vested monthly over four (4) years from the vesting commencement date of January 1, 2020, subject to the Reporting Person's continuous service to the I…

Original filing · 0000905148-26-004080
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RIGL